// App-Quantinova.ai

2650 : Pembrolizumab patient reported benefits: A perspective based on multiple tumors.

Researchers

Presenter

  • Elise Wu

Principal Investigators

  • Paivi H Miskala

  • Mohd Kashif Siddiqui

  • Pankaj Rai

  • Eva Hajdukova

  • Nathalie Erpelding

  • Jacqueline Vanderpuye-Orgle

Medical Centers

  • Merck, North Wales, PA

  • Merck, Rockville, MD

  • Parexel International, Chandigarh, India

  • Parexel International, London, United Kingdom

  • HealthiVibe, LLC., Arlington, VA

  • Parexel international, Billerica, MA

Locations

  • United States

  • India

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved